» Articles » PMID: 39231915

Out-of-pocket Fertility Preservation Expenses: Data from a Japanese Nationwide Multicenter Survey

Abstract

Background: The expenses related to fertility preservation or subsequent assisted reproductive treatments are significant for adolescents and young adult patients in Japan's current healthcare system. With fertility preservation becoming more widespread in developed countries, it is expected that these costs will be covered by insurance or subsidies. It is critical for patients, healthcare providers, and the government to know the costs that patients will be responsible for. In Japan, the costs of fertility preservation and subsequent assisted reproductive technology are not covered by insurance, but patients can apply for subsidies from the local and central governments if certain conditions are met. Presently, the above-mentioned costs, as well as the amount paid by the patient, vary by facility. Therefore, it is essential to ensure patients' continued access to necessary medical care despite the associated costs.

Methods: In this study, questionnaires were mailed to 186 certified fertility preservation facilities in Japan to assess patients who had undergone fertility preservation or assisted reproduction. The questionnaires were sent between October 27, 2023 and March 31, 2024, with 140 of the 186 facilities responding (response rate: 75.3%).

Results: Our findings show that approximately one-third of the costs was borne by the patients.

Conclusion: Given these circumstances, sustainable pricing and insurance coverage are necessary for both patients and facilities.

Citing Articles

Assisted reproductive technology in Japan: A summary report for 2022 by the Ethics Committee of the Japan Society of Obstetrics and Gynecology.

Katagiri Y, Jwa S, Kuwahara A, Iwasa T, Ono M, Kato K Reprod Med Biol. 2024; 23(1):e12620.

PMID: 39677328 PMC: 11646354. DOI: 10.1002/rmb2.12620.

References
1.
Inhorn M, Birenbaum-Carmeli D, Westphal L, Doyle J, Gleicher N, Meirow D . Medical egg freezing: the importance of a patient-centered approach to fertility preservation. J Assist Reprod Genet. 2017; 35(1):49-59. PMC: 5758476. DOI: 10.1007/s10815-017-1081-5. View

2.
Rashedi A, de Roo S, Ataman L, Edmonds M, Silva A, Scarella A . Survey of Fertility Preservation Options Available to Patients With Cancer Around the Globe. JCO Glob Oncol. 2020; 6. PMC: 7853877. DOI: 10.1200/JGO.2016.008144. View

3.
Shigematsu K, Shimizu C, Furui T, Kataoka S, Kawai K, Kishida T . Current Status and Issues of the Japan Oncofertility Registry. J Adolesc Young Adult Oncol. 2022; 12(4):584-591. DOI: 10.1089/jayao.2022.0110. View

4.
. Progestogen-only contraceptives during lactation: II. Infant development. World Health Organization, Task Force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development, and Research Training in Human.... Contraception. 1994; 50(1):55-68. View

5.
Moravek M, Appiah L, Anazodo A, Burns K, Gomez-Lobo V, Hoefgen H . Development of a Pediatric Fertility Preservation Program: A Report From the Pediatric Initiative Network of the Oncofertility Consortium. J Adolesc Health. 2019; 64(5):563-573. PMC: 6478520. DOI: 10.1016/j.jadohealth.2018.10.297. View